ArchPrestige
赞并评论了
$苹果 (AAPL.US)$ beware of a volume spike. if it happens, reversal incoming
1
3
ArchPrestige
赞了
证监会表示
1. 中国监管机构尊重公司决定在哪里上市。
2. 但中国可以命令一家公司处置威胁国家安全的资产或业务。
3. 在海外上市的公司需要获得批准,并确保数据受到保护,上市不会影响国家安全。
https://www.channelnewsasia.com/business/china-proposes-tighter-rules-no-ban-offshore-listings-2400511
$向上融科 (TIGR.US)$ $富途控股 (FUTU.US)$ $滴滴(已退市) (DIDI.US)$ $阿里巴巴 (BABA.US)$ $腾讯控股(ADR) (TCEHY.US)$ $蔚来 (NIO.US)$ $比亚迪(ADR) (BYDDY.US)$
1. 中国监管机构尊重公司决定在哪里上市。
2. 但中国可以命令一家公司处置威胁国家安全的资产或业务。
3. 在海外上市的公司需要获得批准,并确保数据受到保护,上市不会影响国家安全。
https://www.channelnewsasia.com/business/china-proposes-tighter-rules-no-ban-offshore-listings-2400511
$向上融科 (TIGR.US)$ $富途控股 (FUTU.US)$ $滴滴(已退市) (DIDI.US)$ $阿里巴巴 (BABA.US)$ $腾讯控股(ADR) (TCEHY.US)$ $蔚来 (NIO.US)$ $比亚迪(ADR) (BYDDY.US)$
已翻译
26
12
ArchPrestige
赞并评论了
ArchPrestige
赞了
$AMC院线 (AMC.US)$ - 周五的股票已经突破了很多动力。增加了一些短期看涨期权。寻找33美元的突破口。
$Galera Therapeutics (GRTX.US)$ - 上周,Galera宣布Avasopasem第三期ROMAN试验的修正上线疗效数据已经满足主要终点统计显著性。
$辉瑞 (PFE.US)$ - 辉瑞已提交申请,用于12至15岁青少年的COVID-19疫苗批准。可继续上升或下跌。
$Spruce Biosciences (SPRB.US)$ - 辉瑞生物科技股价上涨,Oppenheimer 赋予其外表层级关注评级和15美元的目标价位。
$Galera Therapeutics (GRTX.US)$ - 上周,Galera宣布Avasopasem第三期ROMAN试验的修正上线疗效数据已经满足主要终点统计显著性。
$辉瑞 (PFE.US)$ - 辉瑞已提交申请,用于12至15岁青少年的COVID-19疫苗批准。可继续上升或下跌。
$Spruce Biosciences (SPRB.US)$ - 辉瑞生物科技股价上涨,Oppenheimer 赋予其外表层级关注评级和15美元的目标价位。
已翻译
17
1
ArchPrestige
赞了
$奈飞 (NFLX.US)$ There are naturally negative implications to price cuts, but India has always been a unique market requiring aggressive rate sheets. It may be the world's second-most populous country, but premium pricing is a challenge if you want to go mainstream. The reason why average revenue per user for $迪士尼 (DIS.US)$ 's streaming service is lower now than it was a year ago is because a lot of its subscriber growth has come from its Disney+ Hotstar platform in India.
The timing of the Netflix price cut in India is also interesting. $亚马逊 (AMZN.US)$ had previously announced that the monthly price for its video streaming service was going to rise 39% to $2.35 on Tuesday. Netflix seemingly had the ideal opportunity to inch its price points higher, choosing instead to go the other way to grab market share.
Netflix will be fine, and don't go thinking that you'll be shaving 60% from your stateside subscription anytime soon. The five Netflix hikes for U.S. viewers since early 2014 for its most popular plan have amounted to an increase of between $1 to $2 a month in each case, but over time that's a 75% total increase.
There may very well come a time when the U.S. market will tire of feeding the meter at higher price points. No one has that kind of pricing flexibility. It just doesn't seem as if an isolated move in India would trigger price wars anywhere else in the Netflix playbook.
The timing of the Netflix price cut in India is also interesting. $亚马逊 (AMZN.US)$ had previously announced that the monthly price for its video streaming service was going to rise 39% to $2.35 on Tuesday. Netflix seemingly had the ideal opportunity to inch its price points higher, choosing instead to go the other way to grab market share.
Netflix will be fine, and don't go thinking that you'll be shaving 60% from your stateside subscription anytime soon. The five Netflix hikes for U.S. viewers since early 2014 for its most popular plan have amounted to an increase of between $1 to $2 a month in each case, but over time that's a 75% total increase.
There may very well come a time when the U.S. market will tire of feeding the meter at higher price points. No one has that kind of pricing flexibility. It just doesn't seem as if an isolated move in India would trigger price wars anywhere else in the Netflix playbook.
6
ArchPrestige : 别担心哈哈。闭上眼睛买就行了